-
1
Anti-Tumor Necrosis Factor-α Use in Pediatric Inflammatory Bowel Disease—Reports from a Romanian Center
Published 2025-01-01Subjects: Get full text
Article -
2
Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity
Published 2025-01-01Subjects: Get full text
Article